Two treatment strategies for management of Neurosymptomatic cerebrospinal fluid HIV escape in Pune, India

Symptomatic cerebrospinal fluid (CSF) viral escape (sCVE) is reported in people with HIV, who are on ritonavir-boosted protease inhibitor (PI/r) containing antiretroviral therapy (ART). Management of sCVE includes performing genotypic HIV-1 resistance testing (GRT) on CSF and plasma HIV and changing...

Descripción completa

Detalles Bibliográficos
Autores principales: Dravid, Ameet N., Gawali, Raviraj, Betha, Tarun P., Sharma, Avadesh K., Medisetty, Mahenderkumar, Natrajan, Kartik, Kulkarni, Milind M., Saraf, Chinmay K., Mahajan, Uma S., Kore, Sachin D., Rathod, Niranjan M., Mahajan, Umakant S., Letendre, Scott L., Wadia, Rustom S., Calcagno, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
4850
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7302684/
https://www.ncbi.nlm.nih.gov/pubmed/32541474
http://dx.doi.org/10.1097/MD.0000000000020516

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7302684/
https://www.ncbi.nlm.nih.gov/pubmed/32541474
http://dx.doi.org/10.1097/MD.0000000000020516

Ejemplares similares